OR WAIT 15 SECS
© 2021 MJH Life Sciences™ and Pharmaceutical Technology. All rights reserved.
Darryl Roberts, PhD, Stephen Scypinski, PhD, Mary Oats, PhD, and Joseph Etse, PhD were chosen by the Analytical Research & Development Steering Committee of the PhRMA to draft the aceptable analytical practice guidance document.
Joseph Etse, PhD, Darryl Roberts, PhD, Stephen Scypinski, PhD, and Mary Oats, PhD, were chosen by the Analytical Research & Development Steering Committee of the PhRMA to draft the aceptable analytical practice guidance document.
Stephen Scypinski, PhD, Darryl Roberts, PhD, Mary Oats, PhD, and Joseph Etse, PhD were chosen by the Analytical Research & Development Steering Committee of the PhRMA to draft the aceptable analytical practice guidance document.
Mary Oates, PhD, Darryl Roberts, PhD, Stephen Scypinski, PhD, and Joseph Etse, PhD were chosen by the Analytical Research & Development Steering Committee of the PhRMA to draft the aceptable analytical practice guidance document.
This article presents the findings of PhRMA's annual workshop, held in September 2000, that convened to draft an acceptable analytical practice that would clarify the essential elements of a complete and compliant transfer.